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Abstract.  We have studied the expression of fibulin in 
cultured fibroblasts and determined its primary struc- 
ture by eDNA cloning.  Our results show that fibulin is 
a  secreted glycoprotein that becomes incorporated into 
a  fibriUar extracellular matrix when expressed by cul- 
tured cells or added exogenously to cell monolayers. 
In addition,  we find that fibulin is present in plasma 
at a level of 33  +  3/~g/ml.  Sequencing of multiple 
fibulin cDNAs indicates that a process of alternative 
splicing results in the expression of three fibulin tran- 
scripts.  The transcripts  encode overlapping polypep- 
tides differing only in carboxy-terminal segments. 
Common to the three predicted forms of fibulin is a 
unique 537-amino acid-long cysteine-rich polypeptide 
and a 29-residue signal peptide.  The amino-terminal 
portion of fibulin contains a repeated element with 
potential disulfide loop structure resembling that of the 
complement component anaphylatoxins C3a,  C4a, and 
C5a as well as proteins of the albumin gene family. 
The bulk of the remaining portion of the molecule is a 
series of nine EGF-like repeats. 
F 
mULIN is a recently described calcium-binding  pro- 
tein which has been shown to interact with a synthetic 
peptide representing  the cytoplasmic domain of the 
integrin/~1 subunit as well as native ot5/3~ fibronectin  recep- 
tor  (Argraves  et  al.,  1989).  Indirect  immunofluorescent 
staining of cultured fibroblasts revealed that fibulin colocal- 
ized with the integrin/3~ subunit,  in vivo, at sites of cellular 
interaction  with underlying fibronectin  substratum.  It was 
therefore suspected that fibulin might be an intracellular  pro- 
tein involved with mediating cytoplasmic connections  of the 
/31 integrins.  Herein we report the results  of characteriza- 
tion of fibulin expression and structure.  The results indicate 
that  fibulin  is glycosylated and secreted by cultured fibro- 
blasts and becomes incorporated into an extracellular  matrix 
in a fashion similar to fibronectin.  Salient structural features 
deduced from eDNA clones reveal that fibulin is a multido- 
main protein with two types of repeat motifs, one of which 
is homologous to the anaphylatoxins  C3a, C4a, and C5a, as 
well as elements of proteins of the albumin gene family, and 
the other which is homologous to EGF. 
Materials and Methods 
Antibodies 
The following antisera were used for the immunoprecipitation and im- 
munofluorescent staining experiments described herein: mouse monoclonal 
anti-human fibronectin (not cross-reactive with the bovine fibroneetin used 
in slide coating) was purchased from Telios Pharmaceuticals, La Jolla, CA; 
Kenneth Dickerson's present address is La Jolla Cancer Research Founda- 
tion, La JoUa,  CA 92037. 
mouse monoelonal anti-human integrin #1 subunit was provided by Dr. E. 
Ruoslahti, La Jolla Cancer Research Foundation, La Jolla, CA; and rabbit 
anti-human fibulin serum was prepared in this laboratory and has been de- 
scribed previously (Argraves et al., 1989).  As a precaution, the antifibulin 
serum used in the immunofluorescent staining experiments was absorbed 
on  columns of human  flbronectin and  fibronectin receptor coupled to 
Sepharose. 
For immunoadsorption of fibulin and ELISA, the mouse mAb 5DI2/H7 
was used. This hybridoma cell line was produced by fusion of immune 
mouse spleen cells with myeloma X63Ag8.653 cells according to published 
methods (Ruoslahti et al., 1982).  5D12/H7 reacts specifically with fibulin 
in ELISA, immunoprecipitation, and in immunoblotting under both reduc- 
ing and nonreducing conditions (Dickerson, K., and W. S. Argraves, un- 
published observations). 
Indirect Immunofluorescent Microscopy 
Human gingival fibroblasts (primary fibroblast line obtained from Dr. M. 
Somerman, University of Maryland, Baltimore, MD) were seeded at a den- 
sity of 1.5  x  104 cells/ml onto Lab-Tek chamber slides (Ntmc Inc., Naper- 
viUe,  IL) coated with bovine fibronectin (10 #g/ml, Telios Pharmaceuti- 
cals). Cells were fixed for 30 rain with 3.7% paraformaldehyde (Fluka AG, 
Buchs, Switzerland), 0.1% Triton X-100 in PBS, pH 7.2.  In indicated ex- 
periments, the detergent was omitted from the fxing solution. The slides 
were washed with PBS and then incubated in 3 % normal goat serum-PBS 
(PBS-serum)  for  1 h  at  room temperature.  The primary antisera were 
diluted in PBS-serum and incubated with the fixed cells for 2 h at 37"C. 
The slides were then washed with PBS three times for 5 min. The fluoro- 
chrome-conjugated antisera,  either  fluorescein-conjugated  sheep  anti- 
mouse IgG or rhodamine-conjugated goat anti-rabbit IgG (Cappel Labora- 
tories, Cochranville, PA), were diluted 1:40 in PBS-serum, and incubated 
with the slides for 20 min at room temperature. The slides were again 
washed with PBS. A solution of 50% glycerol in PBS was applied to the 
surface of the slides and a glass coverslip overlaid and fixed to the surface 
with clear nail polish. 
Stained cells were examined and photographed using an Olympus BHS 
microscope equipped for fluorescent microscopy and having additional ex- 
citer filters so as to narrow wavelength bands and restrain crossover excita- 
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taken using Fujichrome 1600 reversal film with exposure settings controlled 
with an Olympus (model  PM-IOADS) exposure control unit. 
Biotinylation of  l~bulin 
The fibu|in used for biotinylation was purified by immunoadsorption from 
extracts  of human placenta. Ground placental tissue was  extracted  with 
4 M KSCN.  Extracts were then clarified by centrifugation, dialyzed against 
TBS,  10 mM EDTA, and passed over a column of plain Sepharose CL-4B. 
The flow-through  was  then applied  to an affinity  matrix of monoclonal 
5DI2/H7 IgG coupled to Sepharose.  The column was washed with 0.5 M 
NaCI,  50 mM Tris,  pH 7.4,  and bound fibulin eluted with a solution of 
4 M KSCN.  The eluted fibnlin was dialyzed against TBS and affinity se- 
lected on wheat germ agglutinin (WGA)~-agarose (see below).  Purified  fi- 
bulin was incubated with sulfo-N-hyroxysuccinimide-biotin  (S-NHS-biotin; 
Pierce Chemical Co., Rockford, IL) in 0.1 M sodium carbonate, pH 8.5 (at 
a  1:200 molar ratio of protein to S-NHS biotin) for 3 h at 4°C.  After the 
reaction, the samples were dialyzed against serum-free DME supplemented 
with penicillin, streptomycin,  glntamine, sodium bicarbonate, and sodium 
pyruvate. 
Gingival cells were grown for 24 h in Lab-Tek chamber slides coated with 
25/~g/mi bovine fibronectin.  Medium was removed and the cell monolayers 
were washed three times with serum-free DME. Biotinylated  fibolin,  hu- 
man fibronectin, and human IgG, each diluted to 0.5 mg/ml in DME-ITS 
(insulin, transferrin, selenous acid,  BSA, and linoleic acid; Collaborative 
Research  Inc., Waltham,  MA) were added separately  to the cells and al- 
lowed to incubate for 12 h at 37°C. The media were removed and the cell 
layers washed three times with PBS. The fluorochrome  conjugate,  FITC- 
avidin (Pierce Chemical Co.), was diluted to 30 #g/ml in PBS, added, and 
incubated for 30 rain at room temperature.  The cell layers were washed 
three times with PBS, mounted, and examined by immunofluorescent  mi- 
croscopy. 
lmmunoprecipitation Analysis 
Nearly  confluent  human gingival fibroblasts,  in  100-mm-diam  culture 
dishes (Becton Dickinson, Lincoln Park, NJ), were radiolabeled for 18 h 
with 250 ~Ci of [35S]cysteine (New  England Nuclear,  Boston, MA) in 
DME (Mediatech, Herdon, VA) containing 10% bovine calf serum sup- 
plemented with iron (HyClone Laboratories, Logan, UT). The media was 
removed and centrifuged at 5,000 g for 15 rain. The media supernatant was 
then dialyzed against 0.5 M NaCI, 2 mM PMSF, 0.1% Triton X-100, 0.1% 
Tween-20, 50 mM Tris-HCl, pH 7.4 (wash buffer) for 18 h at 4°C. The dia- 
lyzed media was pre-cleared with 0.2 vnl of protein A-Sepharose (Sigma 
Chemical Co., St.  Louis,  MO, mixed 1:1 voi/vol in wash buffer).  After a 
1-h incubation, the protein A-Sepharose was removed by centrifugation at 
2,500 g for 5 rain. Antiserum (2 ~,i) was added to 2-ml aliquots of media 
and incubated for 18 h at 4°C. Immune complexes  were precipitated with 
protein A-Sepharose and washed  repeatedly  in wash buffer.  After a final 
wash in TBS, pH 7.4, bound protein was released by addition of SDS elec- 
tropboresis sample buffer and analyzed by SDS-PAGE on 7.5% gels. 
Pulse-chase lmmunoprecipitation Analysis 
Human gingival fibroblasts were grown to near confluence in 35-mm-diam 
culture dishes.  Cell  layers  were  washed  three times with cysteine-free 
RPMI-1640  (Gibco Laboratories, Grand Island, NY) supplemented with 
ITS and 10 mM Hepes,  pH 7.0. The cells were then grown for 15 rain at 
37°C in the cysteine-free RPMI-ITS medium. The cultures were then pulse 
labeled for 2 rain with cysteine-free  RPMI-ITS medium containing 0.5 M 
Ci/ml [35S]cysteine. After the 2-rain pulse labeling the medium was re- 
moved and the cell layers were washed three times with RPMI-ITS contain- 
ing 1 mM unlabeled cysteine,  10 mM Hepes,  pH 7.0, and then allowed to 
incubate for various periods of time in the same medium at 37°C.  At the 
appropriate time intervals, medium was isolated,  and the cell layer extracted 
with 1 ml of 1% Triton X-100, 0.5 M NaC1, 0.05 % Tween 20, 0.05 M Tris- 
HCI, pH 7.4, 2 mM PMSF, using a disposable cell scraper. The cell extracts 
and culture medium fractions were clarified  by centrifugation at  100 g 
in an ultracentrifuge (model TL-100;  Beckman Instruments, Inc.,  Palo 
Alto,  CA).  The resulting  supernatants were pre-absorbed with protein 
A-Sepharose, used in immunoprecipitation, and analyzed by SDS-PAGE as 
1.  Abbreviations  used in  this paper:  PCR, polymerase chain reaction; 
WGA,  wheat germ agglutinin. 
described above.  After SDS-PAGE,  gels  were  treated with Enlightning 
(New England Nuclear, Boston, MA), dried, and used to expose x-ray film 
at -70°C. 
ELISA for Determining l~bulin Concentration 
in Plasma 
To determine the amount of fibulin in plasma, a two-antibody  sandwich 
ELISA was developed.  Microtiter wells were coated overnight with 3/tg/mi 
mouse anti-fibulin monoclonal 5D12/H7  IgG in 0.1 M sodium carbonate 
buffer,  pH 9.5. Nonspecific  binding sites were quenched by addition of 
1 m~/ml BSA in PBS. Human plasma, pooled from five donors, was serially 
diluted and incubated with the antibody coating for 1 h at room temperature. 
Rabbit antifibulin serum at a dilution of 1:10,000 was incubated for 1 h at 
room temperature followed by goat anti-rabbit  IgG alkaline phosphatase for 
an additional hour.  The chromogenic substrate p-nitrophenyl phosphate 
(Sigma Chemical Co.) was used to measure enzymatic activity bound to the 
wells. Resulting absorbance values of the plasma samples were compared 
to those of a serially diluted standard of purified placental fibulin. The con- 
centration of the fibulin standard was determined by protein-dye binding 
assay (Bradford,  1976). 
Lectin AJ~nity Chromatography of FibuUn 
Fibulin was purified from placental extracts by affinity chromatography on 
the synthetic B~ subunit cytoplasmic domain peptide Sepbarose  as previ- 
ously described (Argraves  et al.,  1989).  Fibnlin, in 25 mM octyl-B-v- 
glucoside,  20 mM EDTA, 2 mM PMSE TBS was then applied to a column 
of WGA coupled  to agarose  (Vector Laboratories, Inc., Burlingame,  CA) 
equilibrated in the same buffer. The column was washed with 10 column 
volumes  of TBS and eluted  with 2  column volumes  of TBS containing 
0.5 M N-acetyl-D-glucosamine  (Sigma Chemical Co.).  Eluted protein was 
electrophoresed  on SDS-polyacrylamide gels  and protein bands stained 
using Coomassie blue. 
Detection of N-linked Oligosaccharides 
To determine the presence of N-linked oligosaccharides  on fibulin,  WGA- 
agarose-selected fibniin was  first boiled for 3 min in 0.5%  SDS, 0.1  M 
B-mercaptoethanol  and  then  digested  with N-glycosidase  F  (Genzyme 
Corp., Boston, MA), according to the manufacturer's protocol, for 18 h at 
37°C.  After the digestion,  samples were analyzed by SDS-PAGE. 
Protein Sequence Analysis 
Fibulin was purified from placental extracts by affinity chromatography on 
the synthetic  integrin ~t subunit cytoplasmic  domain peptide Sepharose. 
The affinity-selected material was electrophoresed on SDS-polyacrylamide 
gels  and the  100-kD  flbulin polypeptide electroeluted  from  gel  slices 
(Hunkapiller et al., 1983). This material was digested with trypsin in 0.1 M 
ammonium bicarbonate, pH 8.0, for 18 h at 37°C . The digest was fraction- 
ated on an RP300 column (Applied Biosystems,  Foster City, CA) using 
a microbore HPLC (model  130; Applied Biosystems).  Protein fragments 
from individual peaks were then subjected  to Edman degradation using a 
protein sequencer (model 477A;  Applied Biosystems). 
Isolation and Sequencing of  Fibulin cDNAs 
A human placental eDNA kgtll library (Millan, 1986) was immunologi- 
cally screened (Young and Davis,  1983) using antibodies affinity selected 
from rabbit antifibulin serum (Argraves et al., 1989) on a column of fibulin 
coupled to Sepharose. Clones that expressed insert-encoded  protein reactive 
with these antibodies were  isolated and through successive  screenings 
cloned to homogeneity. Insert cDNAs were subcloned into the phage vector 
M13mpl9 and sequenced by the dideoxy chain termination method (Sanger 
et al.,  1977) using modified  T7 polymerase (United States  Biochemical 
Corp., Cleveland, OH) and synthetic oligonucleotide  primers based on de- 
rived sequences. All sequences reported are based on the sequencing of both 
strands of the  eDNA  inserts.  Sequence analysis and protein database 
searches were performed using PC-Gene (InteUiGenetics,  Mountain View, 
CA) and Seq-it (CompuRight, Newtown,  CT). 
RNA Hybridization Analysis 
Human placental poly(A)  + RNA was electrophoresed in denaturing 0.8% 
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transferred to nitrocellulose (Thomas, 1980). The filters were probed with 
a  150-bp DNA segment generated by polyrnerase chain reaction (PCR) 
(Salld et al.,  1988) using a fibulin eDNA insert at template and upstream 
and downstream oligonucleotide  primers both taken from a region of fibulin 
eDNA common to the three eDNA types.  After hybridization the filters 
were washed under high stringency and used to expose x-ray film at -70°C. 
PCR Analysis 
Total human placental RNA (1 #g) was used with random hexanucleotide 
primer (200  ng,  Pharmacia Fine Chemicals,  Piscataway,  NJ),  RNasin 
(30 U, promega Biotec,  Madison, WI),  1 mM deoxynucleotide  triphos- 
phates (dNTPs), and  Moloney  routine leukemia virus reverse transcriptase 
(200  U,  Bethesda  Research  Laboratories,  C-althersburg,  MD) to  synthesize 
eDNA. Using  1/100  of  the eDNA product,  Taq DNA polymerase  (3 U, 
Stratagene,  La Jolla, CA), upstream and downstream synthetic oligonucleo- 
tide primers (800 ng each), and dNTPs (0.25 mM each), polymerase chain 
amplification was performed. Primer pairs specific for the eDNA of fibulln 
A, B, or C were taken from the following positions within the respective 
target DNA sequence:  1657-1674 and 2142-2159 for A,  1657-1674 and 
2248-2265 for B, and 1442-1459 and 1966-1983 for C. The following tem- 
perature parameters were  cycled 35 times:  1 rain at 94°C, 2 rain at the 
Tin- 4°C of the primer with the lower Tm of the given pair, and 3 rain at 
72°C.  Aliquots of the reactions were analyzed by ngarose gel electrophore- 
sis and the separated DNA was stained with ethidium bromide. 
Results 
Fibulin Is Incorporated into an ExtraceUular Matrix 
We have previously reported that fibulin expressed by cul- 
tured fibroblasts accumulates at sites of expected cellular in- 
teraction with underlying fibronectin  substratum (Argraves 
et al., 1989). The observed pattern of fibulin staining is coin- 
cident with that of the integrin  Bt  subunit.  These results 
were based on experiments  confined to the period of 4-6 h 
after plating  of the fibroblasts  onto fibronectin-coated sur- 
faces. At this early time period, fibulin and the integrin  Bt 
subunit  each  appear  in  immunofluorescent  staining  as 
numerous colocalizing  strealdike  accumulations (Fig.  1, C 
and D). In the absence of permeabilizing  agent,  such stain- 
ing patterns are not evident (Fig.  1, A and B). When we ex- 
tended immunofluorescent  staining  studies  to periods be- 
yond  6  h  we  found  fibulin  accumulated  into  extensive 
fibrillar patterns (Fig.  1 K). Furthermore, the fibrillar stain- 
ing pattern was apparent in the absence of permeabilizing 
agent (Fig. 1 I) indicating that the immunologically detected 
fibulin was extracellular. 
It was also apparent  that the meshwork staining  pattern 
of fibulin  was similar  to that  of fibronectin  (Mautner and 
Hynes,  1977).  Indeed, when double-label immunofluores- 
cent staining  was done using antibodies to both fibulin and 
fibronectin,  very similar  staining patterns were seen both at 
the early and late periods of culture (Fig. 1, G-L). The stain- 
ing patterns obtained using fibulin antibodies could be com- 
pletely blocked by preincubation of the antibodies with 25 
#g/ml fibulin (results not shown). In addition, preincubation 
of fibulin  antibodies with human  fibronectin  at 25 #g/ml 
failed to block antibody staining of fibulin (data not shown). 
A further indicator of fibulin antibody specificity is demon- 
strated  by immunoprecipitation experiments  shown in Fig. 
2. The results indicate that fibulin, like fibronectin,  accumu- 
lates extracellularly,  forming  dense networks of fbrils. 
It  has  been  shown  that  exogenously  added  fibronectin 
binds  to cultured  cell  monolayers,  and becomes assembled 
into a  matrix  (Hayman and Ruoslahti,  1979;  McKeown- 
Longo and Mosher,  1983). To similarly  evaluate the ability 
of exogenously added fibulin to bind to cell monolayers, and 
become incorporated into a matrix, biotinylated  fibulin was 
incubated  with  fibroblast monolayers.  In parallel  experi- 
ments, biotinylated fibronectin and human IgG were also in- 
cubated with fibroblast monolayers as control proteins. After 
12 h of incubation,  the exogenously added biotinylated  fibu- 
lin was found bound to the cell monolayer,  accumulating  in 
elaborate fibrillar networks (Fig.  1 M). A similar pattern of 
incorporation  was  obtained  with  biotinylated  fibronectin 
(Fig. 1 N), but not with biotinylated IgG (Fig. 1 O). The pat- 
terns  of incorporation  of exogenously added  fibulin  and 
fibronectin  closely resembled the patterns  of endogenous 
matrix  accumulation  for each protein  as described above 
(Fig.  1, I-L). 
l~bulin Is Secreted by Cultured Fibroblasts 
The fact that  the immunofluorescent  staining  results  indi- 
cated that fibulin was accumulating  extracellularly  prompted 
us to verify whether cultured cells secreted fibulin into their 
medium.  Culture medium from fibroblasts metabolically ra- 
diolabeled with [3sS]cysteine was analyzed for the presence 
of fibulin. As shown in Fig. 2, fibulin antibodies immunopre- 
cipitate a single polypeptide with an apparent reduced mo- 
lecular mass of 100 kD, which corresponds to that of previ- 
ously  characterized  placental  fibulin.  In  the  absence  of 
reducing  agent,  the  immunoprecipitated  polypeptide  ex- 
hibits the increased electrophoretic mobility characteristic  of 
fibulin. The results indicate that fibulin is secreted by the cul- 
tured fibroblasts. 
To examine the temporal biosynthesis of fibulin,  we per- 
formed pulse-chase immunoprecipitation  analyses.  Within 
the first minutes of chase two immunoreactive polypeptides 
of~80 and 100 kD were present in the cell layer extract (Fig. 
3 A). After 5 min of chase the level of 80-kD polypeptide 
diminished.  Between 30 and 60 min of chase, 100-kD fibulin 
polypeptide appeared in the medium (Fig. 3 B), with a sub- 
sequent decrease in the 100-kD polypeptide in the cell ex- 
tracts.  The results  suggest a precursor-product relationship 
between the 80- and 100-kD polypeptides. The 80-kD band 
may  then  correspond  to  the  nascent  fibulin  polypeptide 
which is  subsequently processed to the  100-kD  molecule 
that is secreted. 
Fibulin Is a Blood Protein 
The presence of fibulin in blood was investigated using im- 
munoadsorption chromatography and ELISA. Plasma, pre- 
absorbed on a column of plain Sepharose,  was passed over 
a column of monoclonal antifibulin  IgG coupled to Sepha- 
rose and eluted with a solution of 4 M KSCN. SDS-PAGE 
analysis showed that the immunologically selected polypep- 
tide displayed  electrophoretic properties  indistinguishable 
from those of placental fibulin (results not shown). Based on 
the results  of a  two-antibody sandwich  ELISA we deter- 
mined the amount of fibulin in plasma to be 33  +  3 (mean 
+  SD) #g/ml. 
Fibulin Is a Glycoprotein 
Generally,  secreted proteins  are glycosylated and  can be 
shown to interact  with various lectins.  We therefore inves- 
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medium. Antifibronectin serum (lanes 1 and 4) and antifibulin se- 
rum (lanes 2 and 3) were used along with protein A-Sepharose  to 
immunoprecipitate  reactive species from culture media of human 
gingival fibroblasts metabolically labeled with [35S]cysteine. Sam- 
pies were electrophoresed in SDS-7.5  % acrylarnide gels under non- 
reducing (lanes I and 2) and reducing (lanes 3 and 4) conditions. 
After electrophoresis the gels were used to expose x-ray film. The 
sizes of protein molecular mass markers are indicated on the fight 
in kilodalton. 
tigated the interaction of fibulin with WGA. Chromatogra- 
phy of placental fibulin preparations on columns of WGA 
coupled to agarose and subsequent SDS-PAGE analysis re- 
vealed that fibulin bound to the lectin and could be eluted 
using a solution of the sugar N-acetyl-glucosamine (Fig. 4). 
No 100-kD polypeptide was found in the material that passed 
through the lectin column (Fig. 4, lane 2) indicating that vir- 
tually all the fibulin bound. The results indicate that fibulin 
is a glycoprotein containing N-acetyl-glucosaminyl carbohy- 
drate constituents. 
Preparations of fibulin were subjected to digestion  with 
N-glycosidase in an effort to estimate the amount of aspara- 
gine (N)-linked oligosaccharide on the polypeptide. As shown 
in Fig. 5, the electrophoretic mobility of fibulin increased af- 
ter digestion with the enzyme. The mobility of the digested 
material corresponded to a molecular mass of 95 kD. Con- 
trois  in  which  fibulin  preparations  were  incubated  under 
similar conditions, without the enzyme, showed no change 
in electrophoretic mobility. Assuming a molecular mass of 
1,500  D  for an average N-linked carbohydrate side chain, 
native fibulin may then have three N-linked oligosaccharide 
chains. 
Figure 3. Pulse-chase labeling and immunoprecipitation analysis of 
fibulin. Fibroblasts  were pulse labeled with cysteine-free growth 
medium containing  [3sS]cysteine and  chased  with  medium con- 
taining unlabeled cysteine. At designated chase time intervals, cul- 
ture medium and cell layer extracts were  subjected to immuno- 
precipitation  with  fibulin  antibodies.  Immunoprecipitates  were 
electrophoretically  separated by SDS-PAGE and the gels analyzed 
by fluorography. Shown are immunoprecipitates  from indicated 
chase  times (in  minutes)  of cell layer  extracts  (.4)  and  culture 
medium (B). 
Fibulin Is Encoded by Multiple Transcripts 
Immunological screening of a  placental eDNA library re- 
sulted in the isolation of seven related clones. As individual 
cDNAs  were  sequenced  it  was  found  that  they  could  be 
categorized into three types (A, B, and C).  The nuclcotide 
sequence of all three types of cDNAs were identical from 
their 5' ends to a  divergence point at position  1707, after 
which they were distinct through to the poly(A) tail.  The 
categorization was therefore based on the sequence following 
the divergence point. Shown in Fig. 6 are the nucleotide se- 
quences determined from the three types of cDNAs isolated. 
Figure 1.  Localization of fibulin in cultured human gingival fibroblasts. A-H represent double-label  immunofluorescent staining images 
from ceils cultured for 4 h on fibronecfin-coated surfaces. These cells were either permeabfliz~ (C, D, G, and H), or nonpermeabilized 
(,4, B, E, and F), and stained with antifibulin (,4, C, E, and G), mouse monoclonal anti-integrin  131 subunit sera (B and D), or mouse 
monoclonal antifibronectin sera (F and H). I-L represent double immunottuorescent staining images done on cells cultured for 24 h on 
fibronectin-coated surfaces. These cells were nonpermeabilized (I and J), or permeabiliz~ (K and L), and stained with antifibulin (I and 
K), and mouse monoclonal antifibronecfin sera (J and K). M-O represent fluorescent images made after fibroblast monolayers were cultured 
in the presence of exogenously added biotinylated fibulin (M), biotinylated fibronectin (N), and biotinylated IgG (O) for 12 h. FITC-avidin 
was used to detect bound biotinylated probes. Control experiments with each of the fluorochrome conjugates gave negligible background 
staining.  Bars:  (A-H) 20/zm; (l-O) 20 t~m. 
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placental fibulin before application to the lectin column (lane 1), 
the flow-through  material (unbound  fraction) (lane 2), and fractions 
sequentially eluted from the column using a solution of N-acetyl 
glucosamine (lanes 3-9).  After the electrophoresis the gel was 
stained with Coomassie blue. 
RNA hybridization analysis was performed using a fibulin 
cDNA fragment common to the three types of eDNA (bases 
84-234, Fig. 6 A) as a probe. As shown in Fig. 7, two tran- 
scripts of '~ 2.4 and 2.7 kb were detected in human placental 
poly(A)  + RNA. To verify that all the isolated cDNAs cor- 
responded to actual transcripts expressed in placental tissue, 
a reverse transcriptase PCR analysis was performed (Rap- 
polee et al.,  1988).  Pairs of synthetic oligonucleotide pri- 
mers, based on sequence from either side of the divergence 
point from each eDNA type, were used in PCR to amplify 
cDNA prepared from placental RNA. The expected sizes for 
amplified products were 502,  606,  and 541  bp for eDNA 
types A, B, and C, respectively. When the products were 
analyzed by agarose gel electrophoresis, fragments of  the ap- 
propriate size were obtained (Fig.  8),  thus confirming the 
presence  of each transcript in total placental  RNA.  The 
product of PCR using the type A-specific primers was re- 
peatedly the lowest in yield. The results indicate that at least 
three forms of fibulin transcripts  exist, most likely made 
through a  process of alternative splicing of a  pre-mRNA 
transcript. 
Figure 5. N-glycosidase  diges- 
tion analysis of fibulin. Coo- 
massie-stalned SDS-polyacryl- 
amide gel of undigested pla- 
cental fibulin (lane 1 ), fibulin 
subjected  to  digestion with 
N-glycosidase  for 18 h at 37°C 
(lane 2), and fibulin incubated 
under similar conditions  of  di- 
gestion minus N-glyeosidase 
(lane 3). 
Fibulin Is a Modular Protein Containing Two 1)1pes 
of  Repeat Motifs 
Polypeptides of 566,  601, and 683 amino acid residues are 
encoded by the type A, B, and C cDNAs, respectively. These 
polypeptides  have  in  common  the  first  566  amino  acid 
residues. The alternative B and C eDNA segments encode 
differing polypeptide elements that add 35 and 117 residues 
to the 566-residue protein.  The amino acid sequence de- 
duced from the cDNAs was found to contain the sequences 
determined from protein sequencing of fibulin including the 
amino-terminal sequence (Argraves et al.,  1989) and three 
sequences derived from tryptic fragments of fibulin (Fig. 6). 
These findings confirmed that the immunologicaUy identi- 
fied cDNAs indeed corresponded to fibulin. Preceding the 
amino-terminal sequence in the deduced type A, B, and C 
sequences is a 29-residue hydrophobic leader sequence that 
has features consistent with it being a signal peptide (Wat- 
son, 1984; von Heijne, 1984). Three potential N-linked gly- 
cosylation sites  (N-X-S/T)  occur  in each of the deduced 
sequences. 
The three forms of fibulin are rich in cysteine ("~11 mol %), 
containing 69, 70, and 72 residues for the A, B, and C forms, 
respectively. Analysis of the sequences with respect to the 
number and spacing of cysteine residues revealed the pres- 
ence of two types of repeat motifs (designated type I and II) 
that each share homology with elements from specific pro- 
teins found in the database. 
The type I  motif has a  consensus  sequence CC(X)~2C- 
(X)9-~oC(X)~CC, and is repeated twice (Fig. 9). Separating 
the two is an imperfect form of this motif that lacks two cys- 
teines. A computer-aided search of the protein database for 
sequences containing the type I  motif or slight variations 
thereof revealed that CC(X)12C(X)~-12C(X)tCC is found in 
complement component anaphylatoxins C3a (de Bruijn and 
Fey, 1985),  C4a (Belt et al., 1984),  and C5a (Wetsel et al., 
1987).  The  inverse pattern,  CC(X)tC(X)tH2C(X)~2CC,  is 
found in  the three  members  of the albumin gene  family 
which include albumin (Brown, 1976),  vitamin D-binding 
protein (Yang et al.,  1985;  Cooke and David,  1985),  and 
o~-fetoprotein (Morinaga et al.,  1983).  The homology find- 
ings suggest that the overall disulfide-stabilized loop struc- 
ture may be conserved between fibulin and these other pro- 
teins even though similarity between residues  other  than 
cysteine in the pattern is unremarkable. 
The type II motif of fibulin is related to the repeats found 
in EGF precursor (Scott et al.,  1983) as well as a number 
of extracellular matrix proteins  (Engel,  1989).  This  six- 
cysteine motif  is repeated consecutively nine times in the se- 
quence of fibulin A, B, and C (Fig. 9). Four of the nine type 
II repeats (2-4 and 9) differ from the typical EGF-like motif 
in that they have a 4-6-residue insertion between cysteines 
4  and 5,  instead of the usual single residue separating the 
two. The ninth type II repeat of fibulin A is imperfect in that 
it lacks a cysteine in the sixth position of  the motif  while fibu- 
lins B and C both have cysteine residues in the vicinity, but 
the spacing of these is not conserved relative to the other 
repeats.  Embodied within four of the nine type II repeats 
(5-8) is a consensus sequence for aspartic acid and aspara- 
gine hydroxylation (Stenflo et al.,  1988).  The seventh type 
II repeat  contains a  consensus  O-glycosylation sequence, 
CXSXPC, that is found in the EGF-like domains of coagula- 
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CCCGCCGCCCATGGAGCGCGCCGCGCCGTCGCGCCGGGTCCCGCITCCGCTGCTGCIGCTCGGC~CCTT~  72 
HERAAPSRRVPLPLLLLGGLA21 
GCTGCTGGCGGCCGGAGTGGACGCGGATGTCCTCCTG~GGCCTGCTGTGCG~CG~CCG~|GGCC~  144 
L  L  A  A  G  V  O  A~O  V  L  L  E  A  C  C  A  D  G  H  R  M  A  I  45  S  X  S  H 
TCATCAG~G~CTGCTCGCTGCCATATGCTACGG~TCCAAAGAAT~AG~TGGT~GC~TG¢IG  216 
H  q  K  ~  C  5  L  P  Y  A  T  E  S  K  E  C  R  R  ¥  Q  E  Q  C  C  69 
E 
CC~CC~CTGG~GAGCT~ACTGTGCCACG~CATCAGCCTGGCC~C~AGGACC~TGT~[~  2~ 
HSQLEELHCATG[SLANEQDRCAT93 
~CCCACGGTG~CGCC~CCTGG~GCC~ATTTGTG~GAGGTGCT~CATTGCTGTCT~TGGG~G  ~0 
PHGDNASLEATFVKRCCHCCLLGR]I7 
GGCG~CCAGGCCCAGGGCCAGAGCTGCG~TACAGCCTCATGGTTGGCT~CAGTGTGGAC~CTTCCG  432 
AAQAQGQSCEYSLHVGYQCGQVFR]4] 
GGCATGCTGTGTCAAGAGCCAGGAGACCGGAGATTTGGATGTCGGGGGCCTCC~GA,CACG~T~TCAT  504 
A  C  C  V  K  S  Q  [  T  G  D  L  D  V  G  G  L  Q  E  T  D  K  1  1  165 
TG~GTT~GGAGG~C~GAGGACCCATATCTG~TGACCGCTGCCGAGGAGGCGGGCCCTGC~GCAGCA  576 
[VEEEQEDPYLHDRCRGGGPCKQ~189 
GTGCCGA~CACGGGT~CGAGGTGGTCTGCTCCTGCTTCGTGGGCTACCAGCTGCTGTCTGATGGTGTCTC  648 
CROTGOEVVCSCFVGYQLLSOGVS213 
CTGTGAAGATGTC~TG~TGCATCACGGGCAGCCACAGCTGCCGGCTTG~G~TCCTGCATC~CACAGT  720 
CEOVNECITGSHSCRLGESCINTV237 
~GCTCTTTCCGCTGCCAGCGGGACAGCAGCTGCGGGACTGGCTATGAGCTCACA~GGAC~TAGCTGC~  792 
GSFRCQROSSCGTGYELTEDNSCK261 
A~TATTG~GAGTGTG~AGTGGTATTCAT~CTGCCTCCCCGATTTTATCTGTCAGAATACTCTGGGATC  864 
D  I  D  E  C  E  5  G  1H  N  C  L  P  0  F  1C  Q  N  T  L  G  S  285 
CTTCCGCTGCCGACCC~GCTACAGTGC~GAGTGGCTTTATAC~GATGCTCTAGGC~CTGTATTGATAT  936 
F  R  C  R  p  K  L  Q  C  K  5  G  F  1Q  D  A  L  G  N  C  1D  1  309 
C~T~GTGTTT~GTATCAGTGCCCCGTGCCCTATTGGGCATACATGCATC~CACA~GGGCTCCTACAC  1008 
NECLSISAPCP[GHTC[NTEGSYT333 
GTGCCAGAAG~CGTGCCCAACTGIGGCCGTGGCTACCATCTCAACGAGGAGGGAACGCGCTGTGTTGATGI  1080 
CQKNVPNCGRGYHLNEEGTRCVDV357 
S 
~AC~GTGCGCGCCACCTGCTGAGCCCTGTGGG~GGGACATCGCTGCGTGAACTCTCCCGGCAGTTICCG  1152 
OECAPPAEPCGKGHRCVNSPGSF8381 
CTGCG~TGC~CGGGTTACTATTTT~CGGCATCAGCAGGATGTGTGTCGATGTCAACGAGTGCCAGCG  1224 
CECKTGYYFDGISRHCVDVNECQR405 
CT~CCCGG~GCCTGTGTG~CAC~GT~G~CACGCT~GCTCCT~CICIGCAGCIGTTCCGIGGG  1296 
YPGRLCGHKCENTLGSYLCSCSVG429 
CTTCCGGCTCTCTGTGGATGGC~GTCATGTG~GACATCAATG~TGC~CAGC~CCCCTGT~CC~GA  1368 
F  R  L  S  V  O  G  R  5  C  E  D  1N  E  C  5  S  5  P  C  5  Q  E  453 
GTGTGCC~CGTCTACGGCTCCTACCAGTGTT~TGCC~CGAGGCTACCAGCTCAGCGATGTG~TGGAGT  1440 
CANVYGSYQCYCARGYQLSDVDGV477 
CACCTGTG~GACATCGACGAGTGCGCCCTGCCCACCGGGGGCCACATCTGCTCCTACCGCTGCATC~CAT  1512 
TCEDIDECALPTGGHICSYSCIN]501 
CCCTGGAAGCTTCCAGTGCAGCTGCCCCTCGTCTGGCTACAGGCTGGCCCCC~TGGCCGC~CTGCC~GA  1584 
PGSF~CSCPSSGYRLAPNGRNCQ0525 
CATTGATG~TGTGTGACTGGCATCCAC~CTGCTCCATC~CGAGACCTGCTTC~CATCC~GGCGCGTT  1666 
IO[CVTGIHNCSI~ET~FNIQGAF649 
F  • 
CCGCTGCCTGGCCTTCGAGTGCCCTGAG~CTACCGCCGCTCCGCAGCCACAT~TCGTAGGGAACTCTGCA  1728 
RCLAFECPENYRRSAAT-  666 
T~GGCCATCGGTGCAGGCTGGAG~GAG~GGC~GTTGGCAG~GTG~GACCAC~ATTT~GCCAC  1800 
TICCTCATGT~CTTAACTTGTGCCTTCAGGACCTGCTC~GCCCGATCACGTATATACCACTTCCATTT~  1872 
TGAIGG~IGCTGCTGTTCAIG~C~CTTTATGGCT~AI~G~AGAAAGCACCCAGllCAT~IA~CA 1964 
GTTCAGGTCATATGGTGACTTGATGACCCAGAGTCAAACATTCAGTTTCCACCAAAGCCCAGT~CAGGCCA  2016 
AGAGCTGTCTCTCAAAAG~GAGTAGTTATCTGCAGAA~T~CAGGGCCTTGCTCCGAAAGCCTA~CC  208B 
GCC~TGTGATTCACCTATGGG~CCTGCCAAAGCTGCAGCC~CATCCTTATCI~C~1~C~CTC~G  2160 
C~CATTGGATCTGCTGGGTCATATGGCCC~GTGGCAGAGC~CTTGCAC~CAGCCT~ACCTGTCATAG  2232 
AGCTTTCTCCTGTTCTGGACCCCACTC~AACTGGCAGCCTTTCAGGTCACTqAATA/U~GTGCTGGAGT~  2304 
C~TCAAACGAGGAATGTGTT~CTCCAAAATCC~T~GCCCAAAAAA  2355 
Figure 6. Nucleotide sequence of the three types of fibulin  cDNAs 
isolated and the corresponding deduced amino acid sequences for 
each form. A shows the complete nucleotide and predicted amino 
acid sequence for the A form of fibulin.  The putative signal peptide 
cleavage site is indicated by an arrow pointing upward.  Protein se- 
quences of the amino terminus and of three tryptic peptides of fibu- 
lin are indicated by solid lines.  Amino acid residues beneath the 
predicted  amino acid  sequence  indicate  differences between the 
cDNA-deduced  sequence and those determined from protein se- 
quencing. Potential N-linked carbohydrate  attachment sites are in- 
dicated by solid squares.  The site where the three types of cDNAs 
diverge is indicated by an arrow pointing downward between 1707 
and  1708.  B and C are sequences of the alternatively spliced seg- 
ments from fibulins B and C, respectively, beginning at nucleotide 
1708.  Sequences  of B  and  C  that  overlap with those of form A 
B 
GCAGAAATCCAAGAAGGGAAG  1728 
Q  g  5  K  K  G  R  573 
GCAGAACACCCCAGCGGGATCAAGTAAAGAGGACTGCAGGGTTCTICCATGGAAGCAGGGGTTGGAGGATAC 1800 
Q  N  T  P  A  G  S  S  K  E  D  C  R  V  L  P  W  K  Q  G  L  E  O  T  597 
CCACCT  TGA'T  GCCT  AGTGAGGAAGATGGACCTGGACAGAC  AG]  CAC,  CTC  CACAC  C'T  TGCGCTGAGCAGCIGT  1872 
H  L  0  A  -  -  601 
GATTGTGCCRCGGGAGCATGAGCCCT  T  TTCCCCACGGCCCTTGCCACTGTCTCCTGGCCCIC~'CTCTGA]CA  1944 
TGCCAGGTTTGCACCAGCCTCGAGTCTCCCATGTTGTAGTACATTCTCCAAGATGCAGCCCAGGAGCCTCTC  2016 
TGAAGGACCAGTCTGGTTACGATGGTC  TGAGCTTCCTTAGAACCTTCCATGGTTGTCTTTTCCCAGCAGATG  2088 
AAGCATAGCCTCCTTGGAATGGCATGGGAGGCCTGGCCTGATCTGGCCTCTGCCCACCCTTTGAGCTGTACC  2160 
TGCCCCACCCCAGCTCATCCATGTGCTTGTACCCTGGCCCCACGGGGAGGCTTGCCCTTCCCTGAATGTGCC  2232 
TTCTTGTGGCTTTAGCATGTGCCATGCTGTCCCCCTGCAGACTGCCATTCTCCTTGCAGACTTGGCTCAGAA  2304 
GTCACCTCC  TCAGTGCAGTI"AGCC  TGAGCTCCCCTGGCCCCAGGTGCCTCCATCAGAGCATTTACCCCATTG  2376 
TGTTGTGGC  TGT  TC  C  TTAACGTCC  CCAC  TAGC  CAGGCTC  TI'TGAGGGC  AGGGATTG  .~.T.~G  TTAATT  TC  T  2448 
GTATTCTC  TGCAACTTTGCAATGTTTGGCTTGAAGAAGGAGCTCAGTAAACATCT(~ATAA/~ATGCAGGTT  2520 
GA  T  G  GAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA  2555 
C 
CCGCTGT~GCGCTTGCCTTG  1728 
R  C  E  R  L  P  C  573 
CCATGAG~TCGGGAGTGCTCC~GCTGCCTCTGAG~TMCCTACTACCACCTCTCTTTCCCCACCMCAT  1800 
HENRECSKLPLRITYYHLSFPTNI597 
CC~GCGCCCGCGGTGGTTITCCGCATGGGCCCCTCCAGTGCTGTCCCCGGGGAC~CATGCAGCTGGCCAT  1872 
QAPAVVFRHGPSSAVPGDSHQLA[621 
C~CGGCGGC~IG~GGGCTTTTTCACC~CCGGMGGT~GCCCCC~TGGGGTGGIG~CCTC~  1944 
T  G  G  N  E  E  G  F  F  T  T  R  K  V  S  P  H  S  G  V  V  A  L  T  645 
C~GCCTGTCC~G~CCC~GG~TTGCTCCT~CCGTC~TG~TCTCTCTCGCCACGGC~CGTC~  2016 
KPVPEPROLLLTVKMDLSRHGTVS~9 
CTCCTTTGTGGCC~GCTTTTCATCTTTGTGTCTGC~CTCT~GC~IC~TTCGCGTCGCGGGGTCTC  2088 
S  F  V  A  K  L  F  I  F  V  5  A  E  L  -  683 
CCTCCTGTTGCTTTCCT~CCCTGCCCTCCGGGGGT  T  TCTTAGC~GCGTGG~CACAGTGAAAA 2160 
22~ 
~ases  ~1707) are not shown. Putative pol~de~lation  s~nal se- 
quences are boxed. These s~uence data are available from EMBL/ 
GenBank/DDBJ  under accession num~  X53741,  X53742,  and 
X53~3  ~r A, B, and C  ~rms, re~ectivel~ 
Figure 7. RNA hybridization analysis show- 
ing  size  of  fibulin  transcripts.  POly(A) + 
human placental  RNA  (3.6 #g)  was dec- 
trophoresed on a 0.8% agarose, 6% formal- 
dehyde gel,  and  transferred  to nitrocellu- 
lose. The filter was incubated with a random 
primed,  32p-labeled  150-bp  fibulin  cDNA 
segment derived from a region common to 
types A, B, and C fibulin  cDNAs.  Sizes of 
standards are indicated on the right in base 
pairs. 
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? 
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<~ = potential  N-glycosylation  site 
qP = potential  O-glycosylation site 
1  = Signal  peptide 
[]  = Type I repeat 
[]=  Type II EGF-like  repeat 
Fibulin  A 
Fibulin  B 
Fibulin  C 
Figure 8. Detection of fibulin A, B, and C mRNAs by reverse Wan- 
scriptase  PCR.  Pairs  of synthetic oligonucleotide  primers taken 
from regions upstream and downstream of the putative splice site 
(position  1707) within fibulin A, B, and C eDNAs were used in 
PCR to amplify eDNA made from human placental  RNA.  The 
products  of the reactions  were electrophoresed  on 1.2% agarose 
gels and stained  with ethidium bromide.  Products of the primer 
pairs specific for fibulin A, B, and C are displayed in lanes 2, 3, 
and 4, respectively. Molecular weight size standards  (lanes I  and 
5) are Hae lI digest of phiX174 DNA with fragment sizes of 1353, 
1078, 872,  603, 310, 281, 234,  and  194 bp. 
tion factors VII, IX, protein Z, and thrombospondin (Nishi- 
mura et al.,  1989).  Immediately following each type II re- 
peat is a pentapeptide with a consensus sequence XD(I/V)(D/ 
N)E.  Separating the third type I repeat and the first type II 
repeat is a  33-residue segment with 36%  (12) of the amino 
acids either aspartic or glutamic acid. The structural organi- 
zation of the three forms of fibulin,  including the arrange- 
ment of the repeat motifs, are schematically represented in 
Fig.  10. 
Discussion 
Our previous results (Argraves et al.,  1989)  suggested that 
fibulin might be an intracellular link between the cytoplas- 
mic domain of the  integrin/3~  subunit  and components of 
the cytoplasm. This was based on the fact that fibulin could 
be purified  by affinity chromatography on  a  peptide  rep- 
resenting the cytoplasmic domain of the integrin/~ subunit 
and that fibulin could be seen by indirect immunofluorescent 
staining of fibroblasts only after permeabilization. This lat- 
ter  observation was based on  immunofluorescent staining 
studies done on fibroblasts grown for 4-6 h on fibronectin- 
coated surfaces. As we again show here, little if any fibulin 
SIGNAL  SEQ. 
TYPE  I 
I  -29) 
30-35) 
1  36-76) 
2  77-111) 
3  112-144) 
MER 
DVL 
AAPSRRVPLPLLLLGGLALLAAGVDA 
LEA 
D "RMNT"N-KDNSLPYATES E©RMVO 
T  I  S  L~NE~-  DR~AT  P  HGDNAS  L  E  AT  F  V 
L  R-  A~QA~GQS~E  YS  LMVGYQ-~GQVF 
i  o 
E  QL  L  Qr-C-"~H  S  E  E 
K: NR 
145-178)  VKS  QET  GDL  DV  GGL  QET  DK  I  I  EV  E  E  EQE  D  P  Y  L  NDR 
TYPE  2 
EGF-LIKE 
1  179-219 
2  (220-265 
3(266-311 
4  (312-359 
5  (360-402 
6  (403-444 
7  (445-486 
8  (485-528 
9  (529-566 
RGG 
ITG 
ESG 
LSI 
APP 
QRY 
SSS 
ALP 
VTG 
GP--  ~KOO--iER  I 
SHS  CRLGE  SIC  I  N 
I  HN  CLPDF  IICON 
SAP  CP  I  GHTIC  I  N 
AEP  CGKGHRIC  V  N 
PGRL  C-  -  GHKICEN 
P  ....  CSQE-  CAN 
T  GGH  I  C-  -  S  Y  RIC  I  N 
I  HN-  -  ~S  I  NETICF 
GDEVVI~ 
Y~RC 
L  RC 
E  TC 
P  RC 
L  LC 
Y  QC 
P  OC 
o  R E 
....  S 
QRDSS 
RPKLQ 
)KNVPN 
....  E 
S 
Y 
S 
-ALFE 
"  GYIOIqLS  oiZlvsl lE ,,F  1 
CGT-  GY  EILITE-  DN-  SIClKIDIIID  El 
CK  S-,GFll  ODAL-[-~N-ICIIIDIIINE  I 
c  G R-  IG YIHI-CIN  E  E~T  .IClVlDIVI o E  I 
CKT  GYYFDG,-SRM,C,.,o,v,NE, 
c s  -IG  V   ]C] IO  I, I" El 
c  R R -I G YIOILI s  O V OIGIV TICIEIO I, I  o E  l 
c  p s  SLG,  YIRILIA  P -  NLG.JR  NICIQL?Jl IDEJ 
cP  E X-,V JR  R S A AT  -COO. 
(567-601  OKS  KKGRONT  P  AGSS  KE  DCRV  L  PWK  QGL  E  DT  HL  DA-COOH  (B  FORM) 
ALT.  SPLICED 
C-TERMINAL  (567-601  RCE  RL  PCHE  NR  ECSKL  P  L  R  I  T  Y  Y  HL  SF  PT  N  I  GAP  A 
SEGMENTS  (602-636  VVF  RMGPSS  AV  PGDSMQLAI  T  GGNE  EGF  F  TT  RK  VS  (C  FORM) 
(635-671  PNSGV  VALT  KP  V  P  E  P  RDL  L  LT  VKMDL  S  RHGT  VS  SF 
(672-683  V  AK  LF  I  F  VS  AE  L-COOH 
Figure 9. Complete amino acid sequence of fibulins A, B, and C. The sequences of repeat motifs I and II have been aligned with spaces 
(-) inserted in the repeats in order to align cysteine residues. 
The Journal of Cell Biology, Volume  111, 1990  3162 staining can be  seen unless such ceils are permeabilized 
(Fig.  1, A, C, E, and G). However,  when we stained these 
cells with a mAb to fibronectin or one recognizing a pre- 
sumed extraceUular determinant of integrin fl~ subunit, we 
also found little or no specific staining unless the cells were 
permeabilized (Fig. 1, B and D, F and H). Evidently, in the 
absence of permeabilizing agents, the close association be- 
tween the cell and the substratum prevents access of antibod- 
ies to sites where fibronectin and integrin are accumulating. 
Therefore, the ability to see staining only after permeabiliza- 
tion may be a misleading indicator that the target antigen is 
an intracellular protein. 
When  we  extended  our  immunofluorescent  staining 
studies to periods beyond 4-6 h, we began to see staining 
of fibulin in the absence of permeabilization (Fig. 1 I). With 
progressive culture time, fibulin was found to accumulate ex- 
tracellularly into extensive fibrillar patterns resembling the 
pattern of accumulation of fibronectin. Using pulse-chase 
labeling and immunoprecipitation analyses, we established 
that fibulin was indeed a secreted protein. Furthermore, we 
showed by lectin affinity chromatography and N-glycosidase 
digestion that fibulin was a glycoprotein containing N-linked 
carbohydrate. These findings were supported by the results 
of  cDNA cloning which showed the predicted amino acid se- 
quence of fibulin to have a signal sequence and three poten- 
tial N-glycosylation  sites. The presence of  the repeated EGF- 
like motif is yet another feature not found in cytoplasmic 
proteins but common to a number of extracellular matrix, 
plasma, and membrane proteins (Engel,  1989).  Taken to- 
gether the findings are consistent with fibulin being an ex- 
tracellular matrix protein rather than a cytoplasmic protein. 
The significance of the fact that fibulin can be purified by 
affinity chromatography on the putative cytoplasmic domain 
of the fll subunit remains to be explained. 
In SDS-PAGE  analysis, fibulin, purified by both affinity 
chromatography and immunoprecipitation,  migrates  as  a 
single band with an apparent molecular mass of 100  kD. 
Based on the results of eDNA cloning it can be predicted that 
there exist three forms of fibulin (designated A, B, and C) 
encoded by three transcripts likely derived from a common 
pre-mRNA. The fact that our fibulin preparations seem only 
to have a single polypeptide may indicate that predominantly 
one form is being isolated. We are attempting to prepare an- 
tisera to synthetic peptides unique to the B and C forms to 
help address this. Another puzzling issue has to do with the 
disparity between the molecular weight of fibulin estimated 
from SDS-PAGE  and that determined from cDNA.  The 
polypeptides  (minus  signal  peptides)  predicted  from the 
nucleotide sequences of the three cDNAs have molecular 
masses of  58,670, 62,561, and 71,551 D. These values are not 
in agreement with fibulin's apparent molecular mass of 100 
kD  obtained  from SDS-PAGE.  Our  results  indicate that 
N-linked glycosylation only accounts for ,,04-5  kD of the 
molecular mass of the 100-kD polypeptide. Other types of 
substitution, such as O-glycosylation, may account for the 
remaining difference. The seventh EGF-like repeat of fibulin 
does contain a consensus O-glycosylation sequence of the 
kind found in the clotting factors VII, IX, protein Z, and 
thrombospondin (Nishimura et al.,  1989).  Overestimation 
of molecular mass by SDS-PAGE  has been reported for a 
number of proteins rich in negatively charged amino acids 
and having low isoelectric point values (Takano et al., 1988; 
Graceffa et al., 1988; Saunders et al., 1989). Fibulins A, B, 
and C have an average content of aspartic and glutamic acid 
residues of 13.5 % and average estimated pI of  4.7. It is there- 
fore possible  that anomalous electrophoretic  behavior of 
fibulin on SDS-PAGE results in an overestimation of its size. 
We demonstrated previously that fibulin is  a  calcium- 
binding protein.  Analysis of the predicted amino acid se- 
quence indicated no sequence homologous to the consensus 
divalent cation-binding sequences of proteins such as cal- 
modulin, troponin C,  and parvalbumin  (Szebenyi et al., 
1981) to be present.  The analysis did reveal however,  the 
presence of four potential asparagine hydroxylation sites, 
CX(D/N)(X),(F/Y)XCXC  (Stenflo et al.,  1988),  embodied 
within  EGF-like  repeats  5-8.  EGF  domains  containing 
/3-hydroxylated  residues have been implicated in calcium 
binding (Sugo et al., 1984) and are found in numerous pro- 
teins including the vitamin K-dependent blood coagulation 
proteins, complement protein ell  low density lipoprotein 
receptor, and thrombomodulin. Work of Ohlin et al. (1988) 
showed that protein C has a  high-affinity calcium-binding 
site residing within an EGF-like element containing/3-hy- 
droxylaspartic acid. Whether the EGF-like domains of fibu- 
lin contain/5-hydroxylated  aspartic acid, or asparagine, and 
bind calcium remains to be determined. 
Based on our sequence analysis of the fibulin cDNAs we 
propose that fibulin is a modular protein containing distinct 
domains that include two types of repeated cysteine-contaln- 
ing motifs and two alternatively spliced elements. In the first 
type of  motif, the arrangement of cysteines closely resembles 
that of sequences found in the complement proteins C3a, 
C4a, and C5a as well as proteins of the albumin gene family. 
The second repeat is homologous to EGE  Whether these 
structural homologies are indicative of functional similari- 
ties is not known. The availability of cDNA and antibody 
probes provide the means to learn more about the expression 
of fibulin in various types of cells and tissues. Future studies 
will focus on understanding the function of fibulin as an ex- 
tracellular matrix and blood protein. 
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